Cargando…
Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment
In recent years, rapid growth of incidence of metabolic syndrome, obesity and diabetes has been noted worldwide. Concurrent non-alcoholic steatohepatitis (NASH) has become a dominant factor of hepatic cirrhosis and hepatocellular carcinoma (HCC). The most important risk factors of transition from NA...
Autores principales: | Straś, Wojciech, Małkowski, Piotr, Tronina, Olga |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592090/ https://www.ncbi.nlm.nih.gov/pubmed/33145423 http://dx.doi.org/10.5114/ceh.2020.99506 |
Ejemplares similares
-
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models
por: Straś, Wojciech Andrzej, et al.
Publicado: (2022) -
Overall Survival in Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Polish Experience
por: Straś, Wojciech, et al.
Publicado: (2021) -
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma
por: Rios, Rafael S., et al.
Publicado: (2021) -
Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention
por: Ip, Blanche C., et al.
Publicado: (2013) -
Hepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management
por: Cholankeril, George, et al.
Publicado: (2017)